A Stronger Foundation for Patient-First Care
Of the approximate 7,000 rare diseases, only a small number have an FDA-approved treatment. When a new drug treatment for a rare disease is approved, it is critical to work with the right specialty pharmacy solutions partner to optimize care management.
AscellaHealth and Optime Care have joined together in our patient-first approach to further enhance the clinical outcomes and journey of specialty and rare disease patients. This Information Brief outlines the key points of our combined strengths and custom services.
Our suite of innovative solutions serves the entire specialty pharmacy industry, including patients, payers, life sciences and providers. Together, we ensure patients have access to high-cost therapies for complex conditions and rare diseases, while optimizing health outcomes.